- Issuer ticker
-
SLRX
- Reported as of
-
30 Dec 2025
- Net transaction value
-
-$17.27
- SEC form
-
4
- Accepted by SEC
-
02 Jan 2026, 17:13:54 UTC
Filing notes and source
Key filing fact
Arnold C. Hanish filed Form 4 for Salarius Pharmaceuticals, Inc. (SLRX) on 02 Jan 2026.
Key facts
- This page summarizes Arnold C. Hanish's Form 4 filing for Salarius Pharmaceuticals, Inc. (SLRX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jan 2026, 17:13.
Change
- Previous filing in this sequence was filed on 24 Nov 2025.
- Current net transaction value: -$17.27.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001233253
Primary reporting owner
HANISH ARNOLD C
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SLRX
transaction
Common Stock
Sale
- Transaction value
- -$9.6
- Shares
- -15
- Change %
- -0.3%
- Price
-
$0.6397
- Shares after
- 5,000
- Date
- 30 Dec 2025
- Ownership
- By Arnold C. Hanish Trust
SLRX
transaction
Common Stock
Sale
- Transaction value
- -$7.68
- Shares
- -12
- Change %
- -100%
- Price
-
$0.6397
- Shares after
- 0
- Date
- 30 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.